HemMobile vs PPF 2023

HemMobile® is a convenient, all-in-one app designed to support people living with hemophilia and their caregivers. It makes it easy to track treatments, monitor bleeds, and stay organized— right from your mobile device. With HemMobile®, you can log infusions and injections, document bleeds with photos and details, track daily activity, and access helpful patient resources. You can also review your history and quickly share reports with your care team. Key features include: • Log the date, time, location, and reason for every infusion or injection • Record important treatment details like lot number, expiration date, and IU dosage • Document and track bleeds with mapping and photos • Generate and share reports with your care team • Locate nearby hemophilia treatment centers (HTCs) and support organizations • Set reminders for medications, appointments, and care needs • Manage multiple patient profiles—ideal for caregivers supporting more than one individual HemMobile® is not intended for curing, treating, seeking treatment for managing or diagnosing a specific disease, disorder, or any specific health condition. While Pfizer supports the HemMobile app, the products that can be logged will not exclusively be manufactured by Pfizer.

The Plasma Protein Forum (PPF) is the premier conference for the plasma protein therapeutics industry in North America. This annual event brings industry, policymakers, health care providers, scientists, and patients together to learn more about and discuss key developments and issues. The 2023 PPF will be held November 14-15 in Washington, D.C. The PPF is organized by the Plasma Protein Therapeutics Association (PPTA), a dynamic trade association that represents a unique sector of the biologics and biotechnology industry. PPTA represents more than 1,000 human plasma collection centers in North America and Europe, as well as the manufacturers of lifesaving plasma protein therapies. Our members produce approximately 80% of the plasma protein therapies in the U.S. and 60% of those manufactured in Europe. PPTA works globally to: advocate for access to and affordability of therapies for patients, engage in constructive dialogue with regulatory agencies, and collaborate with patient advocacy organizations.